Dr. Theresa Deisher

President, Sound Choice Pharmaceutical Institute 

Dr. Theresa Deisher

Dr. Deisher’s career has focused on discovering and developing new therapies for grievous human illness. Dr. Deisher obtained her PhD in Molecular and Cellular Physiology from Stanford University and has spent over 19 years in commercial biotechnology, working with such illustrious companies as Genentech, Repligen, ZymoGenetics, Immunex and Amgen, prior to founding AVM Biotechnology and Sound Choice Pharmaceutical Institute.

Dr. Deisher is an inventor on 23 issued US patents, and her discoveries have led to clinical trials of FGF18 for osteoarthritis and cartilage repair, and for Factor XIII for surgical bleeding. Dr. Deisher was the first person to discover adult cardiac derived stem cells, and has been a champion of adult stem cell research, both professionally and privately two decades.  She is a frequent lecturer on the stem cell issues delving into topics such as; research, clinical progress, policy, economics and ethics. She provides a breath of fresh air with a common sense approach which allows lay audiences to readily grasp the issues. Dr. Deisher has appeared on numerous radio shows, televised debates and live on The World Over Live with Raymond Arroyo.